XXVI International Society of Thrombosis and Hemostasis (ISTH) Congress 2017 and 63rd Annual Scientific and Standardization Committee (SSC)
Event Date: July 8 - 13, 2017
Event Location: Berlin, Germany
Diapharma will be attending and exhibiting at ISTH 2017. Please click here to schedule a meeting with us or email us directly.
ISTH 2017
Through an extensive lineup of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities, the Congress promotes important scientific discourse and advancement.
The ISTH 2017 Congress will be the foremost global meeting in thrombosis, hemostasis and vascular biology, and will be attended by thousands of the world’s experts. You will gain insights into the most recent scientific advances, exchange the latest research and discuss how clinical applications can be best applied to improve the lives of patients around the world. Join Diapharma at ISTH 2017 and together, we will transcend scientific boundaries!
Areas in thrombosis and hemostasis at the ISTH 2017 meeting will include:
Atherothrombosis & Stroke
- Atherothrombosis & Stroke
- Atherosclerosis
- Cardiovascular Risk Factors
- Ischemia-reperfusion Injury
- Myocardial Infarction
- Peripheral Vascular Disease
- Stroke
Coagulant & Anticoagulant Mechanisms
- Animal Models in Thrombosis & Hemostasis
- Coagulation Factors and Inhibitors
- Coagulation Proteins Beyond Hemostasis
- Contact Pathway
- FVIII/IX
- Protein C Pathway
- Regulation of Coagulation
- Tissue Factor Pathway
Coagulation Signaling & Immunity
- Complement and Hemostatic System
- Hemostatic Signaling
- Infection & Hemostatic Factors
- Inflammation and Sepsis
- Innate & Adaptive Immunity
- Platelets & Inflammation
- Protease Activated Receptors
Diagnostics and OMICs
- Bioinformatics & Systems Biology
- Biomarkers of Thrombosis & Haemostasis
- Epigenetics
- Laboratory Diagnostic
- Nanotechnology
- OMICs
Fibrinolysis & Proteolysis
- Cellular & Tumor Proteases
- Coagulation and Cancer
- Fibrinogen and Factor XIII
- Fibrinolytic Factors and Inhibitors
- Thrombolytic Therapy
Hemorrhagic Disorders, Hemophilia
- Acquired Hemorrhagic Coagulation Disorders
- Disseminated Intravascular Coagulation
- Hemophilia – Basic
- Hemophilia – Clinical
- Hemophilia Gene Therapy
- Hemorrhagic Disorders, Pediatric Aspects
- Management of Bleeding & Trauma
- Novel Biotherapeutics in Hemophilia
- Rare Bleeding Disorders
- VWF and von Willebrand Disease
Management of Thromboembolism
- Arterial Fibrillation
- DOACs
- Heparins & Heparinoids
- Novel Anticoagulants
- Post-thrombotic Syndrome
- Pregnancy Complications
- Thromboembolism, Pediatric Aspects
- Vitamin K Antagonists
Pathogenesis of Thromboembolism
- Antiphospholipid Syndrome
- Cancer-Associated Thrombosis
- Genetic Risk Factors of Thrombosis
- Hemostasis & Organ Dysfunction
- Microparticles
- Thrombophilia
Pediatrics
- Diagnosis and management of inherited bleeding disorders in children
- Diagnosis and management of acquired bleeding disorders in children
- Epidemiology of pediatric thrombosis
- Diagnosis of pediatric thrombosis
- Anticoagulant prophylaxis and treatment in children
Platelets – Basic
- Megakaryotes & Thrombopoiesis
- Platelet Antagonists
- Platelets Beyond Hemostasis
- Platelet Function and Interactions
- Platelet Proteomics and Genomics
- Platelet Receptors
- Platelet Signaling
Platelets – Clinical
- ADAMTS13/TTP
- Antiplatelet Therapy
- HIT and ITP
- HUS/Thrombotic Microangiopathies
- Platelet Disorders, Acquired
- Platelet Disorders, Inherited
- Platelets, Pediatric Aspects
Transfusion & Biotherapeutics
- Blood Components, Production and Substitution
- Cellular Therapies & Blood Cell Farming
- Novel Biomolecules
- Patient Blood Management
- Safety & Inactivation of Blood Components
Vascular Biology & Angiogenesis
- Angiogenesis & Vasculogenesis
- Blood Cells and Vessel Wall
- Endothelial Cell Signaling
- Non-coding RNAs
- Vascular Progenitor and Stem Cells
ISTH
The International Society on Thrombosis and Haemostasis (ISTH) is a global not-for-profit membership organization advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders.
The Society is dedicated to transformative scientific discoveries and clinical practices, the development of young professionals and the education of physicians, scientists and allied health professionals wherever they may live. The ISTH initiates and promotes education and outreach initiatives, research activities, scientific meetings, peer-reviewed publications, expert committees and the development of standards allowing a common language and approach to basic and clinical science all over the world.
ISTH History
In 1954, a small group of investigators used seed money from the National Heart, Lung and Blood Institute (NHLBI) to form the International Committee on Thrombosis and Haemostasis (ICTH).
The members were well-known for their contributions to the fields of blood coagulation and hemorrhagic disorders, so news about their group spread quickly within the scientific community.
Interest grew, and the ICTH began to consider expanding the scope of its mission. The number of scientists who wanted to attend its meetings increased each year, but because of its small size, the Committee could only accommodate a few attendees..
